Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas
NCT01898078
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Lymphoma
Interventions
DRUG:
Alisertib
Sponsor
Millennium Pharmaceuticals, Inc.